Despite rising profitability, the stock price hasn't risen as expected indicating other influencing factors. The growth in revenue over 5 years presents opportunities yet negative Total Shareholder Return shows risk. Investors should heed the company's 2 warning signs.
$莱斯康制药 (LXRX.US)$I made a separate comment on this one with a chart analysis... this is my top watch for swing trades $Resideo Technologies (REZI.US)$this is a lot like LXRX, but it broke key resistance today and now is looking to fill a gap to $13+
Resideo Technologies股票讨论区
$Resideo Technologies (REZI.US)$ this is a lot like LXRX, but it broke key resistance today and now is looking to fill a gap to $13+
暂无评论